PEABODY, Mass., Jan. 27, 2011 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), a leading provider of medical imaging and aviation security technology, announced today that the Company has shipped its 1,000th EXACT® (EXplosive Assessment Computed Tomography) system. The EXACT is incorporated in the TSA-certified eXaminer 3DX® Explosives Detection System (EDS), developed by Analogic and L-3 Communications.
The eXaminer 3DX is installed in airports in 26 countries. The system features advanced CT imaging technology to examine the contents of checked baggage and enable automatic detection of explosives. The eXaminer family of government-certified systems also includes the eXaminer SX and eXaminer XLB systems. These complimentary systems address throughput and workflow needs of small to very large airports.
Jim Green, president and CEO, said, "We are very proud to celebrate this major milestone. The shipment of the 1,000th EXACT, which we developed in 1997, is a testament to the important role this time-tested airport security system continues to play in the marketplace. For nearly two decades, the TSA has relied on our engineering and manufacturing expertise to help protect the air-traveling public. We remain committed to providing the TSA with the most advanced CT-based imaging technology available."
Analogic (Nasdaq:ALOG), headquartered in Peabody, Mass., is a high-technology company that designs and manufactures advanced medical imaging and security systems and subsystems sold to original equipment manufacturers (OEMs) and end users in the healthcare and homeland security markets. We are recognized worldwide for advancing state-of-the-art technology in the areas of computed tomography (CT), magnetic resonance imaging (MRI), digital radiography, ultrasound, and automatic explosives detection for airport security. Our OEM customers incorporate our technology into systems that they in turn sell for various medical and security applications. We also sell our ultrasound products directly to clinical end-user markets through our direct worldwide sales force under the brand name BK Medical. For more information, visit .
CONTACT: Mark Namaroff Director of Investor Relations & Corporate Marketing (978) 326-4058 email@example.com